Signaling in B cells via Toll-like receptors

Current Opinion in Immunology

Volumn 17, Issue 3, 2005, Pages 230-236

  Peng, Stanford L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ANTIBODY PRODUCTION; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CPG ISLAND; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOREGULATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL;

ANIMALS; B-LYMPHOCYTES; DNA-BINDING PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 18844380660     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.03.003     Document Type: Review

References (44)

1. S. Akira, and K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
2. E. Bourke, D. Bosisio, J. Golay, N. Polentarutti, and A. Mantovani The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells Blood 102 2003 956 963 This study demonstrates the preferential expression of TLRs 9 and 10 on activated human B cells, suggesting that B cell responses to TLR ligands are likely to be regulated by the expression of the TLRs themselves.
3. N.L. Bernasconi, N. Onai, and A. Lanzavecchia A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells Blood 101 2003 4500 4504 This study demonstrates that TLR9 is induced in human B cells in response to activation, and that B cell sensitivity to CpG DNA requires simultaneous triggering through the BCR, suggesting that regulated expression of TLR9 prevents polyclonal activation in a primary response.
4. M. Wagner, H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J.W. Ellwart, and S. Endres IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA J Immunol 172 2004 954 963 To promote a Th1-skewing effect in human B cells, CpG oligonucleotides require an additional co-stimulatory stimulus such as CD154 (CD40L). Interestingly, this study finds no role for TLR4 signaling in either naïve or memory human B cells.
5. A. Iwasaki, and R. Medzhitov Toll-like receptor control of the adaptive immune responses Nat Immunol 5 2004 987 995
6. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu Rev Immunol 21 2003 335 376
7. E. Latz, A. Schoenemeyer, A. Visintin, K.A. Fitzgerald, B.G. Monks, C.F. Knetter, E. Lien, N.J. Nilsen, T. Espevik, and D.T. Golenbock TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nat Immunol 5 2004 190 198 This study demonstrates that TLR9 is localized to the endoplasmic reticulum of dendritic cells and macrophages, and redistributes to CpG DNA-containing structures resembling the lysozyme to initiate MyD88 signaling.
8. F. Takeshita, I. Gursel, K.J. Ishii, K. Suzuki, M. Gursel, and D.M. Klinman Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9 Semin Immunol 16 2004 17 22
9. M. Kimoto, K. Nagasawa, and K. Miyake Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide Scand J Infect Dis 35 2003 568 572
10. Y. Kikuchi, S. Koarada, Y. Tada, O. Ushiyama, F. Morito, N. Suzuki, A. Ohta, K. Miyake, M. Kimoto, and T. Horiuchi RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies Arthritis Rheum 46 2002 3259 3265 A circulating B cell population that lacks RP105 expression is found to be highly activated and responsible for autoantibody production in systemic lupus erythematosus, suggesting that differential LPS signals can modulate autoreactive B cells in this disease.
11. D.M. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides Nat Rev Immunol 4 2004 249 258
12. 2a) B cells via the synergistic engagement of the B cell receptor and TLR9.
13. ••] to demonstrate that hypomethylated mammalian DNA can activate anti-DNA B cells via the BCR and TLR9.
14. L. Rui, C.G. Vinuesa, J. Blasioli, and C.C. Goodnow Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling Nat Immunol 4 2003 594 600 Here, anergic B cells are demonstrated to have uncoupled the BCR pathway from signaling events that synergize with TLR9 ligation. Continuous ERK signaling inhibits CpG-induced activation, indicating that the mechanisms that prevent TLR ligand-induce autoimmunity in vivo might involve the modulation of intrinsic signaling activities.
15. Y. Wang, and A.M. Krieg Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides Vaccine 22 2004 2641 2650
16. A.M. Krieg CpG motifs in bacterial DNA and their immune effects Annu Rev Immunol 20 2002 709 760
17. 3 via both TLR9 and MyD88.
18. 1 and IgE in murine B cells. The Tbox transcription factor T-bet is implicated as the mechanism of action, but studies in knockout B cells indicate that T-bet is not required for this phenomenon [19].
19. S.L. Peng, J. Li, L. Lin, and A. Gerth The role of T-bet in B cells Nat Immunol 4 2003 1041
20. 3 by a mechanism that cooperates with IL-10. Interestingly, significant immunoglobulin secretion appears to require additional factors, such as BAFF and BCR signaling.
21. F. Gantner, P. Hermann, K. Nakashima, S. Matsukawa, K. Sakai, and K.B. Bacon CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides Eur J Immunol 33 2003 1576 1585
22. A. Kato, T. Ogasawara, T. Homma, J. Batchelor, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto CpG oligodeoxynucleotides directly induce CXCR3 chemokines in human B cells Biochem Biophys Res Commun 320 2004 1139 1147
23. H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help Blood 103 2004 3058 3064 The requirements for plasmacytoid differentiation in human B cells by CpG-C oligonucleotides are demonstrated to require also BCR ligation and plasmacytoid dendritic cells.
24. M. Muzio, D. Bosisio, N. Polentarutti, G. D'Amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L.P. Ruco, and P. Allavena Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells J Immunol 164 2000 5998 6004
25. F. Aosai, M. Chen, H.K. Kang, H.S. Mun, K. Norose, L.X. Piao, M. Kobayashi, O. Takeuchi, S. Akira, and A. Yano Toxoplasma gondii-derived heat shock protein HSP70 functions as a B cell mitogen Cell Stress Chaperones 7 2002 357 364
26. J.C. Rassa, J.L. Meyers, Y. Zhang, R. Kudaravalli, and S.R. Ross Murine retroviruses activate B cells via interaction with toll-like receptor 4 Proc Natl Acad Sci USA 99 2002 2281 2286
27. •].
28. •] demonstrate that, at least for some heat shock proteins, contaminating endotoxin accounts for their TLR stimulatory activities.
29. Y. Mita, K. Dobashi, K. Endou, T. Kawata, Y. Shimizu, T. Nakazawa, and M. Mori Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4 Immunol Lett 81 2002 71 75
30. P. Massari, P. Henneke, Y. Ho, E. Latz, D.T. Golenbock, and L.M. Wetzler Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent J Immunol 168 2002 1533 1537
31. A.H. Hovav, L. Davidovitch, G. Nussbaum, J. Mullerad, Y. Fishman, and H. Bercovier Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect Infect Immun 72 2004 3383 3390
32. J.O. Previato, R. Wait, C. Jones, G.A. DosReis, A.R. Todeschini, N. Heise, and L.M. Previato Glycoinositolphospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology Adv Parasitol 56 2004 1 41
33. J. Lee, T.H. Chuang, V. Redecke, L. She, P.M. Pitha, D.A. Carson, E. Raz, and H.B. Cottam Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7 Proc Natl Acad Sci USA 100 2003 6646 6651
34. S.S. Diebold, T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA Science 303 2004 1529 1531
35. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 Science 303 2004 1526 1529
36. J.M. Lund, L. Alexopoulou, A. Sato, M. Karow, N.C. Adams, N.W. Gale, A. Iwasaki, and R.A. Flavell Recognition of single-stranded RNA viruses by Toll-like receptor 7 Proc Natl Acad Sci USA 101 2004 5598 5603
37. S. Bauer, C.J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G.B. Lipford Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition Proc Natl Acad Sci USA 98 2001 9237 9242
38. J. Vollmer, R. Weeratna, P. Payette, M. Jurk, C. Schetter, M. Laucht, T. Wader, S. Tluk, M. Liu, and H.L. Davis Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities Eur J Immunol 34 2004 251 262
39. M. Jurk, B. Schulte, A. Kritzler, B. Noll, E. Uhlmann, T. Wader, C. Schetter, A.M. Krieg, and J. Vollmer C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level Immunobiology 209 2004 141 154
40. M. Heikenwalder, M. Polymenidou, T. Junt, C. Sigurdson, H. Wagner, S. Akira, R. Zinkernagel, and A. Aguzzi Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration Nat Med 10 2004 187 192 Continuous CpG oligonucleotide administration to mice surprisingly induces an immunodeficient state, altering lymphoid organ morphology and inducing multifocal liver necrosis.
41. C. Pasare, and R. Medzhitov Toll-like receptors: balancing host resistance with immune tolerance Curr Opin Immunol 15 2003 677 682
42. V. Hornung, S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides J Immunol 168 2002 4531 4537
43. K.A. Zarember, and P.J. Godowski Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines J Immunol 168 2002 554 561
44. L.C. Hsu, J.M. Park, K. Zhang, J.L. Luo, S. Maeda, R.J. Kaufman, L. Eckmann, D.G. Guiney, and M. Karin The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 Nature 428 2004 341 345